prikaz prve stranice dokumenta MSCT probir raka pluća
  Download
PDF 1.38 MB
master's thesis
MSCT probir raka pluća
2019. urn:nbn:hr:176:955214
Valenta, Nada
University of Split
University Department of Health Studies

Cite this document

Valenta, N. (2019). MSCT probir raka pluća (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:176:955214

Valenta, Nada. "MSCT probir raka pluća." Master's thesis, University of Split, University Department of Health Studies, 2019. https://urn.nsk.hr/urn:nbn:hr:176:955214

Valenta, Nada. "MSCT probir raka pluća." Master's thesis, University of Split, University Department of Health Studies, 2019. https://urn.nsk.hr/urn:nbn:hr:176:955214

Valenta, N. (2019). 'MSCT probir raka pluća', Master's thesis, University of Split, University Department of Health Studies, accessed 14 March 2023, https://urn.nsk.hr/urn:nbn:hr:176:955214

Valenta N. MSCT probir raka pluća [Master's thesis]. Split: University of Split, University Department of Health Studies; 2019 [cited 2023 March 14] Available at: https://urn.nsk.hr/urn:nbn:hr:176:955214

N. Valenta, "MSCT probir raka pluća", Master's thesis, University of Split, University Department of Health Studies, Split, 2019. Available at: https://urn.nsk.hr/urn:nbn:hr:176:955214

Please login to the repository to save this object to your list.
Metadata
TitleMSCT probir raka pluća
Title (english)MSCT SCREENING OF THE LUNG CANCER
AuthorNada Valenta
MentorTade Tadić (mentor)
Committee memberTade Tadić (član povjerenstva)
Committee memberIvana Štula (član povjerenstva)
Committee memberKrešimir Dolić (predsjednik povjerenstva)
GranterUniversity of Split
University Department of Health Studies
Split
Defense date and country2019-09-04, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract
Rak pluća najčešći je uzrok smrti povezan s pojavom raka u svijetu. U vrijeme dijagnoze, rak pluća često je već u naprednoj fazi. Opservacijska ispitivanja kod visokorizične populacije pokazala su da detekcija raka pluća probirnom nisko doznom spiralnom tomografijom (LDCT) detektira više karcinoma pluća nego detekcija rendgenskom snimkom pluća. Daljnja randomizirana ispitivanja potrebna su za uspoređivanje smrtnosti specifičnoj za bolest između skenirane i neopažene populacije. Kada bolesnik prvi put počne program probira LDCT-om za rak pluća, dijagnosticirani rak pluća može biti u uznapredovaloj fazi, iako je bolesnik asimptomatski. Optimiziranje ciljne populacije za probir raka pluća ima ogroman značaj, ne samo za pojedince koji teže riziku i prednostima, nego i za zdravstvene djelatnike, zdravstveno osiguranje i vladu koja moraju razmotriti fiskalni učinak provođenja probira raka pluća. Hipoteza NELSON studije je da probirom raka pluća nisko doznim spiralnim CT-om se može smanjiti 10-godišnja smrtnost raka pluća za 25% kod visoko rizičnih pušaća u razdoblju od 50 do 75 godine starosti. NLST i NELSON studije uključile su dva bitna rizik za rak pluća: godine i povijest pušenja. Moguće je da s boljim prognozama rizika, probir može biti učinkovitiji, s više dijagnosticiranih karcinoma pluća i manjim rizikom izlaganja štetnom ionizirajućem zračenja kod pojedinaca.
Abstract (english)
Lung cancer is the most common cause of death, related in cancer worldwide. At the time of diagnosis, lung cancer is often already at an advanced stage. Observational studies in a high-risk population showed that detection of lung cancer by low-dose helical tomography (LDCT) screening detected more lung cancer than lung X-ray detection. Further randomized trials are needed to compare disease, specific mortality between the scanned and unnoticed populations. When a patient first begins a LDCT screening program for lung cancer, the diagnosed lung cancer may be at an advanced stage, although the patient is asymptomatic. Optimizing the target population for lung cancer screening is of tremendous importance, not only for individuals at risk and benefits, but also for healthcare professionals, health insurance and government, who must consider the fiscal impact of conducting lung cancer screening. The NELSON study hypothesis is that lung cancer screening with low-dose helical CT can reduce 10-year lung cancer mortality by 25% in high-risk smokers between 50 and 75 years of age. NLST and NELSON studies have included two significant risks for lung cancer: age and smoking history. It is possible that with better risk forecasts, screening may be more effective, with more diagnosed lung cancers and less risk of exposure to harmful ionizing radiation in individuals.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:176:955214
Study programmeTitle: Radiologic Technology (university/graduate)
Study programme type: university
Study level: graduate
Academic / professional title: magistar/magistra radiološke tehnologije (magistar/magistra radiološke tehnologije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2020-07-02 17:09:24